Trademark applications and grants for Janssen Sciences Ireland Unlimited Company. Janssen Sciences Ireland Unlimited Company has 37 trademark applications. The latest application filed is for "VYLADRO"
State Incorporated | IRELAND |
Entity Type | private unlimited company |
Address | Barnahely Ringaskiddy, Co. Cork IRELAND |
Patent Application | Date |
---|---|
CARBOHYDRATE NANOCARRIER DELIVERY OF HEPATITIS B VIRUS (HBV) VACCINES 20220305118 - 17/596862 HORTON; Helen ;   et al. | 2022-09-29 |
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAI 20220305117 - 17/596753 HORTON; Helen ;   et al. | 2022-09-29 |
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND PYRIDOPYRIMIDINE DERIVATIVES 20220305115 - 17/596210 HORTON; Helen ;   et al. | 2022-09-29 |
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND SMALL MOLECULE PDL1 OR PD1 INHIBITOR 20220305114 - 17/596061 HORTON; Helen ;   et al. | 2022-09-29 |
LIPID NANOPARTICLE OR LIPOSOME DELIVERY OF HEPATITIS B VIRUS (HBV) VACCINES 20220305108 - 17/596839 HORTON; Helen ;   et al. | 2022-09-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.